Alkermes, Inc. (NASDAQ:ALKS)

Alkermes Could Win Big With New Biogen Partnership

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain to start the week, after the firm announced that it has entered into a global license agreement with Biogen Inc. (NASDAQ: ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Stocks were indicated to open higher on Monday, and investors understand that the Dow, S&P and Nasdaq are all fighting for all-time highs again. The trend that has ruled without ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cheniere, Con-Ed, Foot Locker, Shopify, Tesla, Veeco, Zoetis and Many More

Stocks were indicated to open higher on Tuesday, and even the Nasdaq was indicated higher after some of its top market darlings have recovered from Friday's and Monday's selling pressure. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Alcoa, Amazon, ArcelorMittal, Corning, Intel, Vale, AMD and More

Stocks were indicated marginally lower on Friday ahead of several economic reports. This was the last day of the quarter, and the Dow was up 5.4% and the S&P 500 ...
Read Full Story »
Money and plant

Hot Tech and Biotech Companies Highlight Jefferies Stocks to Buy

With earnings coming full throttle again this week, and investors battening down the hatches for the final few weeks of what has been a torturous presidential campaign, top firms on ...
Read Full Story »
thumbs up

Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?

Alkermes PLC (NASDAQ: ALKS) saw its shares surge on Friday after positive news on ALKS 5461 for depression in Phase 3 studies. This was for patients who do not respond to ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
Wow

4 Stocks That Punished Shareholders Last Week

This was the third week of trading for 2016, and many shareholders were affected this week as we saw broad markets and China crumble. Both the Dow Jones Industrial Average ...
Read Full Story »
clinical trials

Why Alkermes Top-Line Results Might Not Be as Bad as Once Thought

Alkermes PLC (NASDAQ: ALKS) absolutely tanked early Thursday morning on less than favorable top-line results. The company announced preliminary top-line results from the first two of three Phase 3 efficacy ...
Read Full Story »
Stock Quotes

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

Now that there has been a biotech bloodbath seen of late, many fundamental and technical analysts have been looking for stocks that either are grossly oversold or are now greatly ...
Read Full Story »
biotech

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

Politicians with a bully pulpit have been known to cause controversy, and Hillary Clinton's vow to take on the drug industry has walloped the share prices on many pharmaceutical and ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: American Airlines, CyberArk, Delta Air, First Solar, VMware and Many More

Stocks were indicated lower again on Tuesday after weak data out of China, like that somehow couldn't be seen coming. Investors have so far bought the dips and sell-offs, but ...
Read Full Story »
fda_logo

5 Big FDA Decisions Expected in August

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »